title: Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
authors.affiliation: Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut, USA. silvio.inzucchi@yale.edu
authors.forename: Silvio E
authors.initials: SE
authors.lastname: Inzucchi
authors.forename: Richard M
authors.initials: RM
authors.lastname: Bergenstal
authors.forename: John B
authors.initials: JB
authors.lastname: Buse
authors.forename: Michaela
authors.initials: M
authors.lastname: Diamant
authors.forename: Ele
authors.initials: E
authors.lastname: Ferrannini
authors.forename: Michael
authors.initials: M
authors.lastname: Nauck
authors.forename: Anne L
authors.initials: AL
authors.lastname: Peters
authors.forename: Apostolos
authors.initials: A
authors.lastname: Tsapas
authors.forename: Richard
authors.initials: R
authors.lastname: Wender
authors.forename: David R
authors.initials: DR
authors.lastname: Matthews
mesh_terms: D000367:Age Factors; D000465:Algorithms; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000453:epidemiology / Q000628:therapy*; D005060:Europe / Q000453:epidemiology; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000453:epidemiology / Q000628:therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000097:blood / Q000453:epidemiology / Q000628:therapy*; D008107:Liver Diseases / Q000453:epidemiology / Q000628:therapy*; D008297:Male; D018802:Patient-Centered Care; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; C517652:hemoglobin A1c protein, human